NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-160-2009-2-LI-26 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LI EP 09795720.3 Abandoned
NINDS E-160-2009-2-LU-28 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LU EP 09795720.3 Abandoned
NINDS E-160-2009-2-BE-09 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis BE EP 09795720.3 Abandoned
NINDS E-160-2009-2-AT-08 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis AT EP 09795720.3 Abandoned
NINDS E-160-2009-2-FI-18 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis FI EP 09795720.3 Abandoned
NINDS E-160-2009-2-FR-19 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis FR EP 09795720.3 Abandoned
NINDS E-160-2009-2-DK-15 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis DK EP 09795720.3 Abandoned
NINDS E-160-2009-2-EE-16 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis EE EP 09795720.3 Abandoned
NINDS E-160-2009-2-DE-14 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis DE EP 09795720.3 Abandoned
NINDS E-160-2009-2-EP-04 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis EP National Stage 09795720.3 Abandoned
NINDS E-160-2009-2-AU-02 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis AU National Stage 2009345604 Abandoned
NINDS E-160-2009-2-MX-06 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MX National Stage MX/A/2011/011494 Abandoned
NINDS E-160-2009-2-US-07 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis US National Stage 12/768,930 8347984 Abandoned PDF
NINDS E-160-2009-2-PCT-01 Quinone derivative 2, 3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis PCT PCT COMB PCT/EP2009/009148 Expired
NICHD E-016-1996-0-US-28 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS US DIV 12/641,172 8003629 Abandoned PDF
NIAID E-285-2002-0-JP-19 Lutzomyia Longipalpis Polypeptides and Methods of Use JP DIV 2009-285970 Abandoned
NCI E-028-2007-0-US-08 Novel Insertion Sites In Pox Vectors US CON 12/639,781 Abandoned
NINDS E-143-2002-1-JP-11 Method For the Treatment of Multiple Sclerosis JP DIV 2009-284862 Abandoned
NCI E-050-2010-0-US-01 Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL US 61/287,139 Abandoned
NCI E-141-2008-0-US-07 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof US National Stage 12/666,052 9931377 Issued PDF
NCI E-256-1999-0-US-15 Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith US DIV 12/638,747 7993857 Expired PDF
NICHD E-010-2010-0-US-01 Method For The Detection Of A Subdural Hematoma For Use In A Handheld Hematoma Detector And Discriminator. US 61/286,626 Abandoned
NINDS E-155-2006-0-US-07 Novel Neuroactive Steroids US National Stage 12/664,470 8575375 Issued PDF
NCI E-113-2003-0-AU-06 Target Activated Microtransfer AU DIV 2009250964 Expired
NCI E-200-2007-0-US-03 Inactivators Of 06-Alkylguanine-DNA Alkytransferase US National Stage 12/597,773 8188055 Issued PDF
NIAID E-249-2007-0-US-02 Cloned Genome of Infectious Hepatitis C Virus Strain HC-TN and Uses Thereof US DIV 12/637,696 Abandoned
NCATS E-268-2009-0-US-01 DELIVERY OF A THERAPEUTIC PROTEIN, TRANSTHYRETIN (TTR), ACROSS THE BLOOD-BRAIN BARRIER (BBB) AS A TREATMENT FOR ALZHEIMER'S DISEASE. US 61/286,205 Abandoned
NINDS E-007-2009-0-PCT-02 Agents That Selectively Inhibit CD25 On Dendritic Cells or T-cells And Their Use PCT PCT PCT/US2009/067755 Expired
NIAID E-240-2007-0-US-04 Chimeric SLE/Dengue Type 4 Antigenic Viruses US National Stage 12/664,293 Abandoned
NCI E-180-2008-0-PCT-02 Identification Of A Novel Fusion Transcript On Chromosome 16p Disrupted By Inherited Mutations In Developmental Retardation Syndromes And By Somatic Mutations In Cancer PCT PCT PCT/US09/67502 Abandoned
NIAID E-146-2004-0-US-03 Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (PA) Toxin US National Stage 11/793,735 8685396 Abandoned PDF
NCI E-321-2003-0-CA-07 A Human Cytotoxic T-lymphocyte Epitope And Its Agonist Epitope From the Non-Variable Number Of Tandem Repeat Sequence Of MUC-1 CA National Stage 2547635 Expired
NIAID E-239-2007-3-US-01 PSM Peptides As Vaccine Targets Against Methicillin-Resistant Staphylococcus US CIP 12/631,253 8211445 Issued PDF
NIAID E-055-2009-0-PCT-02 USE OF A ROCK INHIBITOR TO SUSTAIN PRIMARY HUMAN KERATINOCYTES IN A PROLIFERATIVE STATE PCT PCT PCT/US2009/066844 Expired
NIMH E-054-2009-0-PCT-02 Drugs That Target PIK3CD Are Effective Treatments Of Schizophrenia, Psychosis, And Cognitive Deficiency PCT PCT PCT/US2009/066867 Expired
NIMH E-054-2009-0-EP-05 Drugs That Target PIK3CD Are Effective Treatments Of Schizophrenia, Psychosis, And Cognitive Deficiency EP National Stage 09771628.6 Abandoned
NHLBI E-291-2009-0-US-01 HYDRAZONE AND DIACYL HYDRAZINE COMPOUNDS AND METHODS OF USE US 61/266,760 Abandoned
NIMH E-054-2009-0-CA-04 Phosphatidylinositol-3-kinase p110 delta-Targeted Drugs in the Treatment of CNS Disorders CA National Stage 2745280 Abandoned
NIMH E-054-2009-0-AU-03 Phosphatidylinositol-3-kinase p110 delta-Targeted Drugs in the Treatment of CNS Disorders AU National Stage 2009322187 Abandoned
NCI E-296-2008-0-US-02 Anti-Cancer Oligodeoxynucleotides US ORD 12/630,315 8053422 Abandoned PDF
NHLBI E-292-2009-0-US-01 Signal-To-Noise Enhancement Imaging Application Using Time Series of Images US 61/266,442 Abandoned
NIDDK E-049-2010-0-US-01 (N)-Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates As A3 Receptor Agonists US 61/266,084 Abandoned
NCI E-108-2004-0-US-02 Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas US DIV 12/592,778 Abandoned
CC E-077-2002-0-US-05 Computer-Aided Classification of Anomalies in Anatomical Structures US DIV 12/627,958 8189890 Expired PDF
NHLBI E-047-2009-0-US-01 A New Synthetic ApoA-1 Mimetic Amphipathic Peptide With Specificity For Cholesterol Efflux US 61/265,291 Abandoned
NCI E-133-2009-0-US-01 Use Of Tempol For Treatment Of Cancer US 61/265,194 Abandoned
NCI E-250-2008-0-EP-03 Quantitative Oxygen Imaging Systems and Methods Using Echo-Based Single Point Imaging EP National Stage 09829806.0 Issued
NCI E-250-2008-0-CH-05 Quantitative Oxygen Imaging Systems and Methods Using Echo-based Single Point Imaging CH EP 09829806.0 Issued
NCI E-250-2008-0-GB-08 Quantitative Oxygen Imaging Systems and Methods Using Echo-based Single Point Imaging GB EP 09829806.0 Issued
NCI E-250-2008-0-DE-06 Quantitative Oxygen Imaging Systems and Methods Using Echo-based Single Point Imaging DE EP 09829806.0 Issued